|
Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model |
Sutcliffe P, Connock M, Pulikottil-Jacob R, Kandala NB, Suri G, Gurung T, Grove A, Shyangdan D, Briscoe S, Maheswaran H, Clarke A |
|
|
Record Status This is a systematic review that meets the criteria for inclusion on DARE. Bibliographic details Sutcliffe P, Connock M, Pulikottil-Jacob R, Kandala NB, Suri G, Gurung T, Grove A, Shyangdan D, Briscoe S, Maheswaran H, Clarke A. Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model. Health Technology Assessment 2013; 17(53): 1-499 Indexing Status Subject indexing assigned by NLM MeSH Age Factors; Cardiotonic Agents /economics /therapeutic use; Cost-Benefit Analysis; Great Britain; Heart Failure /mortality /therapy; Heart-Assist Devices /adverse effects /economics; Humans; Models, Economic; Quality of Life; Quality-Adjusted Life Years; State Medicine; Technology Assessment, Biomedical AccessionNumber 12013068777 Date bibliographic record published 12/12/2013 |
|
|
|